Clinical Trial Software for Small Biotech

Clinical trial software for small biotech: speed, flexibility, and 21 CFR Part 11–aligned EDC without enterprise implementation overhead.

21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required

How small biotech teams work in Capture.Study

On the Capture side, small biotech teams typically have a handful of core users: a study builder or outsourced CRO partner, one or more study managers, and site staff at a limited number of sites. Everyone accesses the same web-based application—mirroring what you see on the Capture.Study marketing site and demo page—so there is no need to roll out heavy client software or manage local installations. This makes it easier to onboard new sites or expand into additional studies as your pipeline grows.

  • Study configuration happens in the browser; no local installations or custom development required
  • Sites log in to Capture to see visit schedules, enter data into CRFs, and manage queries
  • Monitors and data managers can review data and raise queries from anywhere, using the same application
  • Your team can scale from one study to several without changing platforms or rebuilding integrations

Planning for growth with a small biotech clinical stack

The goal for small biotech is not just to run a single study, but to build a foundation that can support later-stage trials, partnerships, or acquisitions. Capture’s focus on configuration, exports that map into standard analysis workflows, and documentation for validation helps you avoid painting yourself into a corner with one-off tools or spreadsheets. As you progress to larger programs, you can continue using the same platform with more sites, more modules, and more internal users, rather than replacing your stack.

  • Reuse configurations and CRF libraries from early pilot or Phase 1 studies in later programs
  • Provide potential partners or acquirers with clear documentation of systems, controls, and validation activities
  • Avoid the need to replatform when you move from small early-phase to larger trials
  • Keep control of your data and processes while still working with CROs or other external partners

Overview

Clinical Trial Software for Small Biotech

Small biotech sponsors need clinical trial software that gets studies live quickly without enterprise implementation cycles or per-seat pricing that doesn’t scale. Many small sponsors are running their first translational or early clinical programs while simultaneously raising capital and building out their teams. Your stack should support EDC, consent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls—so you can focus on the science, not lengthy vendor onboarding. It should also help you avoid getting locked into technology choices that are hard to unwind later: configuration-driven builds, clear exports, and validation documentation that you can carry forward as your organization grows. Capture is built for small biotech: rapid build, flexible amendments, and documentation to support validation when you need it, without enterprise overhead.

Why small biotech needs different software

Small biotech teams run lean: you need speed to first dose and first patient, flexibility to amend protocols as data comes in, and one system that doesn’t require large IT or long change-control cycles. Enterprise trial software often adds implementation time and cost that doesn’t fit early-stage budgets. At the same time, investor and partner expectations for data quality, auditability, and compliance are high. Capture emphasizes speed, flexibility, and 21 CFR Part 11–aligned controls without enterprise implementation overhead, so you can meet those expectations with a practical stack that your team can operate.

Common small biotech workflow

  • Protocol and consent; ethics and regulatory submissions
  • Fast site activation (often one or few sites)
  • Screening, consent, enrollment; safety and efficacy capture
  • AE and conmed capture; data review and queries
  • Database lock and export for analysis and regulatory use
  • Reuse of successful designs for follow-on or extension studies

Traditional tool pain points

  • Months of implementation before study start
  • Enterprise pricing and long contracts for small studies
  • Heavy change control for protocol and form updates
  • Separate vendors for EDC, consent, and ePRO
  • Limited support for rapid build and amendments
  • Lack of in-house IT resources to manage complex systems

How Capture supports small biotech

  • Rapid study build and go-live without enterprise implementation cycles
  • Unified EDC, eConsent, ePRO, and safety in one platform
  • Flexible amendments with full audit trail
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Documentation for sponsor validation (Enterprise); pricing that scales with study size

Related

EDC for early-phase trialsFeaturesPricing

FAQ

Questions we hear a lot

Is Capture built for small biotech?
Yes. Capture is designed for early-stage and small sponsors. We emphasize speed, flexibility, and avoiding enterprise implementation overhead. You get one platform with 21 CFR Part 11–aligned controls and documentation to support validation.
How do we avoid long implementation?
Study build can start as soon as you have protocol and CRF requirements. Many small biotech teams deploy in weeks. We provide documentation and support for qualification and UAT when required for regulated studies.
What about compliance?
Capture is designed with 21 CFR Part 11–aligned controls and HIPAA-aligned security. We do not make unsubstantiated validation claims; we provide documentation to support your validation approach (Enterprise).
Can we start with one study and add more later?
Yes. Many small biotech sponsors begin with a single early-phase or pilot study on Capture and then expand to additional trials as their pipeline grows, reusing configurations and CRF libraries as needed.
Do we need in-house IT to manage Capture?
No. Capture is delivered as a web application. Configuration and day-to-day management are handled through the browser, so most small biotech teams can operate the platform without dedicated IT staff.
Can we work with CROs while keeping control of our data?
Yes. You can grant CRO partners role-based access to your studies while retaining overall control of configuration, data, and exports. Access and activity are tracked in the audit trail.
How does pricing work for small sponsors?
Capture is designed to avoid heavy enterprise pricing and long-term contracts. For small sponsors, pricing is aligned with study size and scope rather than unlimited enterprise deployment. Specific commercial terms are handled outside of the application configuration.
Can we support both sponsor-led and investigator-initiated studies?
Yes. Small biotech sponsors often support a mix of sponsor-led and investigator-initiated work. Capture can be configured for each study type while using the same underlying platform and controls.
How do we handle audits or due diligence from partners or investors?
Because consent, CRFs, safety data, and audit trails all live in one platform, it is easier to demonstrate how your studies are run and controlled during audits or due diligence. We can provide system documentation as part of Enterprise engagements to support these reviews.
Can Capture grow with us as we move into larger trials?
Yes. The same platform can be used for larger Phase 2/3 programs by adding sites, visits, and users as your pipeline expands, so you do not need to replatform when you move beyond small early-phase studies.

Ready to see Capture in action?

Explore the platform with a free sandbox. No sales call required.